
A Phase II Single Arm Trial of Elective Volume Adjusted De-Escalation Radiotherapy (EVADER) in Patients with Low-risk HPV-related Oropharyngeal Squamous Cell Carcinoma

A Phase III Study Of Standard Fractionation Radiotherapy With Concurrent High-Dose Cisplatin Versus Accelerated Fractionation Radiotherapy With Panitumumab In Patients With Locally Advanced Stage III And IV Squamous Cell Carcinoma Of The Head And Neck.

Randomized Phase II Study of Cisplatin plus Radiotherapy versus Durvalumab plus Radiotherapy followed by Adjuvant Durvalumab versus Durvalumab plus Radiotherapy followed by Adjuvant Tremelimumab and Durvalumab in Intermediate Risk HPV-Positive Locoregionally Advanced Oropharyngeal Squamous Cell Cancer (LA-OSCC)
Inventory
Show Tissue Samples
Disease Site | Trial Code | Patients Accrued | Patients - Blocks | Patients - Slides | Patients - Blocks and/or Slides |
HEAD AND NECK | HN10 | 103 | 48 | 53 | 98 |
HEAD AND NECK | HN6 | 320 | 142 | 89 | 208 |
HEAD AND NECK | HN9 | Open Trial | 70 | 71 | 100 |
(Core size is 0.6 mm)
Show
Fluid SamplesDisease Site | Trial Code | Patients Accrued | TMA Blocks | Patients on TMA Blocks |
HEAD AND NECK | HN10 | 103 | 0 | 0 |
HEAD AND NECK | HN6 | 320 | 2 | 16 |
HEAD AND NECK | HN9 | Open Trial | 0 | 0 |
Disease Site | Trial Code | Patients Accrued | Patients - Whole Blood | Patients - Cellular Component of Blood | Patients - DNA extracted from Blood | Patients - RNA extracted from Blood | Patients - Plasma | Patients - Serum | Patients - Urine | Patients - Buccal |
HEAD AND NECK | HN10 | 103 | 99 | 0 | 0 | 0 | 99 | 0 | 0 | 0 |
HEAD AND NECK | HN6 | 320 | 1 | 263 | 0 | 0 | 263 | 266 | 0 | 0 |
HEAD AND NECK | HN9 | Open Trial | 100 | 0 | 0 | 0 | 100 | 78 | 0 | 0 |